Skip to main content

Table 1 The demographic and clinical characteristics of women with PCOS and non-PCOS control

From: Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry

Item

PCOS group (n = 19)

Control group (n = 21)

p value

Age (y)

30.1 ± 2.3

32.5 ± 4.1

0.24

BMI (kg/m2)

23.9 ± 4.4

22.7 ± 2.3

0.29

Duration of infertility (y)

1.6 ± 1.5

1.5 ± 1.4

0.83

Primary infertility, n (%)

8 (42.1%)

10 (47.6%)

0.73

FSH (mIU/ml)*

6.6 ± 1.6

7.4 ± 1.0

0.31

LH (mIU/ml)*

5.3 ± 3.5

6.0 ± 8.7

0.75

E2 (pg/ml)*

42.7 ± 25.2

35.9 ± 15.0

0.30

T (ng/ml)*

0.50 ± 0.49

0.36 ± 0.23

0.25

AFC*

20.5 ± 10.1

10.2 ± 5.7

< 0.001

E2 on HCG day(pg/ml)

4375.9 ± 1203.8

2420.6 ± 1411.9

< 0.001

P on HCG day(ng/ml)

1.6 ± 0.6

1.2 ± 0.5

0.03

Days of gonadotropin use (d)

11.3 ± 2.8

10.6 ± 3.4

0.48

Total Gonadotropin dose (U)

2109.3 ± 815.5

2941.9 ± 1173.6

0.01